Glenmark Pharmaceuticals Europe Limited
Every public sector contract Glenmark Pharmaceuticals Europe Limited has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows Glenmark Pharmaceuticals Europe Limited for you, and alerts you the moment a renewal goes live.
Where they win
The sectors, tender types and buyers where Glenmark Pharmaceuticals Europe Limited wins most often.
See every live NHS tenders and find your next contract before they do.
See all NHS buyers and UK contract awards.
Sectors
Top Buyers
Awards(16)
NHS National Generic Pharmaceuticals - Wave 16a
Generic, Branded Generic & Proprietary Medicinal Products - Group 18
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender
NHS National Framework for Transition products commencing 1 October 2024
NHS National Framework for Transition products commencing 1 May 2024
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024
NP43324 HIV Generic Medicines
NP Generic Medicines Transition Tender (October 2023)
NHS National Generic Pharmaceuticals Wave 14b
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals
NHS National Generic Pharmaceuticals Wave 14a
NHS Framework Agreement for Branded medicines - National
NHS Framework Agreement for Branded Medicines - National Tender
National Procurement for HIV and Preventative Treatments
National Procurement for HIV and Preventative Treatments
NHS National Generic Pharmaceuticals Wave 13
Know when Glenmark Pharmaceuticals Europe Limited's contracts come up for renewal
Business predicts when each of these contracts is due to be re-tendered, follows Glenmark Pharmaceuticals Europe Limited for you, and alerts you the moment a renewal goes live, so you can bid before the incumbent locks it in again.
Why track Glenmark Pharmaceuticals Europe Limited?
Glenmark Pharmaceuticals Europe Limited is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.
How renewal tracking works
We aggregate Glenmark Pharmaceuticals Europe Limited's award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.
What you can do here
- Review the full history. Every contract Glenmark Pharmaceuticals Europe Limited has won, with the buyer, value and dates for each.
- Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
- Track and get alerted. Follow Glenmark Pharmaceuticals Europe Limited and be notified when their contracts come up again (Business).
- Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.
Frequently asked questions
Where does this data come from?
Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.
Is the contract history free?
Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.
How do you predict renewals?
From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.